FTC sues to stop drugmaker Amgen from completing $27.8 billion deal
Washington Post
The Federal Trade Commission is seeking to block Amgen’s $27.8 billion deal to acquire Horizon Therapeutics, the regulator’s first challenge to a pharmaceutical merger in years.
https://www.washingtonpost.com/business/2023/05/16/ftc-lawsuit-amgen-pharmaceutical-deal/